BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 2380644)

  • 21. Postmortem diagnosis of diabetes mellitus. Quantitation of fructosamine and glycated hemoglobin.
    Valenzuela A
    Forensic Sci Int; 1988 Sep; 38(3-4):203-8. PubMed ID: 3192143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of fructosamine in the screening and evaluation of the metabolic control of the diabetic patient].
    Veillon H; Rieder A; Stara B; Darioli R
    Schweiz Rundsch Med Prax; 1988 May; 77(22):613-7. PubMed ID: 3387756
    [No Abstract]   [Full Text] [Related]  

  • 23. [Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
    Mercelina LF; Degenaar CP; Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 1989 Sep; 133(38):1887-90. PubMed ID: 2797305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum fructosamine assay in the evaluation and follow-up of diabetics].
    Shapiro MS; Ludvinovsky S; Weiss E; Arber I
    Harefuah; 1990 Apr; 118(8):447-9. PubMed ID: 2358226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
    Lapolla A; Poli T; Barison A; Fedele D
    Diabetes Res Clin Pract; 1988 Feb; 4(3):231-5. PubMed ID: 3359924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects.
    Negoro H; Morley JE; Rosenthal MJ
    Am J Med; 1988 Sep; 85(3):360-4. PubMed ID: 3414731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum fructosamine: a parameter for monitoring metabolic control in diabetes.
    Gomo Z
    Cent Afr J Med; 1992 Sep; 38(9):358-62. PubMed ID: 1298563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis.
    Trenti T; Cristani A; Cioni G; Pentore R; Mussini C; Ventura E
    Ric Clin Lab; 1990; 20(4):261-7. PubMed ID: 2075378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy.
    Parfitt VJ; Clark JD; Turner GM; Hartog M
    Diabet Med; 1993 Mar; 10(2):162-6. PubMed ID: 8458194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipoprotein and apolipoprotein levels in young insulin-dependent diabetic patients. Relations with glycosylated hemoglobin and fructosamine].
    Willems D; Dorchy H
    Presse Med; 1990 Jan 6-13; 19(1):17-20. PubMed ID: 2137219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The why and wherefore of fructosamine.
    Mendlovic DB; Whitehouse FW; Foreback CC
    Henry Ford Hosp Med J; 1992; 40(1-2):149-51. PubMed ID: 1428970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of serum fructosamine in short term glycemic control.
    Prior TW; Chapman JF; Bankson DD
    Ann Clin Lab Sci; 1989; 19(2):107-13. PubMed ID: 2751240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum fructosamine in patients with diabetes mellitus.
    Baker J; Reid I; Holdaway I
    N Z Med J; 1985 Jul; 98(782):532-5. PubMed ID: 3861965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New diagnostic tests for diabetes mellitus. Hemoglobin A1 (A1c) and fructosamine].
    Okuda Y; Itakura M; Yamashita K
    Nihon Rinsho; 1989 Nov; 47(11):2467-71. PubMed ID: 2601058
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical utility of serum fructosamine in diabetes mellitus compared with hemoglobin A1c.
    Jerntorp P; Sundkvist G; Fex G; Jeppsson JO
    Clin Chim Acta; 1988 Jul; 175(2):135-42. PubMed ID: 3409529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].
    Tryggeseth A
    Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2539-40. PubMed ID: 2219017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of HbA1 and fructosamine in predicting impaired glucose tolerance--an alternative to OGTT to detect diabetes mellitus or gestational diabetes.
    Salemans TH; van Dieijen-Visser MP; Brombacher PJ
    Ann Clin Biochem; 1987 Sep; 24 ( Pt 5)():447-52. PubMed ID: 3662394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation.
    Howey JE; Bennet WM; Browning MC; Jung RT; Fraser CG
    Diabet Med; 1989 Dec; 6(9):793-6. PubMed ID: 2533039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.